| Literature DB >> 32354205 |
Chang-Kyu Oh1, Ji Wan Kang2, Yoonsung Lee1, Kyungjae Myung1, Mihyang Ha2, Junho Kang2, Eun Jung Kwon2, Youngjoo Kim2, Sae-Ock Oh3, Hye Jin Heo3, Shin Kim4,5, Yun Hak Kim3,6.
Abstract
Relapse of acute lymphoblastic leukemia (ALL) is dangerous and it worsens the prognosis of patients; however, prognostic markers or therapeutic targets for ALL remain unknown. In the present study, using databases such as TARGET, GSE60926 and GSE28460, we determined that KIF2C and its binding partner, KIF18B are overexpressed in patients with relapsed ALL compared to that in patients diagnosed with ALL for the first time. As 50% of the residues are exactly the same and the signature domain of KIF2C is highly conserved between human and zebrafish, we used zebrafish embryos as a model to investigate the function of kif2c in vivo. We determined that kif2c is necessary for lymphopoiesis in zebrafish embryos. Additionally, we observed that kif2c is not related to differentiation of HSCs; however, it is important for the maintenance of HSCs as it provides survival signals to HSCs. These results imply that the ALL relapse-related gene KIF2C is linked to the survival of HSCs. In conclusion, we suggest that KIF2C can serve as a novel therapeutic target for relapsed ALL.Entities:
Keywords: ALL; GEO; KIF2C; TARGET; hematopoiesis; zebrafish
Mesh:
Substances:
Year: 2020 PMID: 32354205 PMCID: PMC7246619 DOI: 10.3390/ijms21093127
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Patient characteristics in the four cohorts.
| Variables | TARGET | TARGET | GSE60926 | GSE28460 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosis | Relapse | Diagnosis | Relapse | Diagnosis | Relapse | Diagnosis | Relapse | |||||
| ( | ( | ( | ( | ( | ( | ( | ( | |||||
|
| ||||||||||||
| Male | 74 (55.2) | 64 (55.2) | 1 | 42 (55.3) | 42 (55.3) | 1 | 15 (68.2) | 14 (70.0) | 0.878 | / | / | / |
| Female | 60 (44.8) | 52 (44.8) | 1 | 34 (44.7) | 34 (44.7) | 1 | 6 (27.3) | 5 (25.0) | 0.75 | / | / | / |
|
| ||||||||||||
| <10 | 79 (59.0) | 69 (59.5) | 0.963 | 44 (57.9) | 44 (57.9) | 1 | 16 (72.7) | 14 (70.0) | 0.821 | / | / | / |
| ≥10 | 55 (41.0) | 47 (40.5) | 0.955 | 32 (42.1) | 32 (42.1) | 1 | 6 (27.3) | 6 (30.0) | 0.721 | / | / | / |
|
| ||||||||||||
| Positive | 6 (4.5) | 4 (3.4) | 0.695 | 3 (3.9) | 3 (3.9) | 1 | / | / | / | / | / | / |
| Negative | 105 (78.4) | 86 (74.1) | 0.121 | 58 (76.3) | 58 (76.3) | 1 | / | / | / | / | / | / |
| Unknown | 23 (17.2) | 26 (22.4) | 0.683 | 15 (19.7) | 15 (19.7) | 1 | / | / | / | / | / | / |
|
| ||||||||||||
| White | 94 (70.1) | 81 (69.8) | 0.979 | 54 (71.1) | 54 (71.1) | 1 | / | / | / | / | / | / |
| Asian | 4 (3.0) | 2 (1.7) | 0.548 | 2 (2.6) | 2 (2.6) | 1 | / | / | / | / | / | / |
| Black or African American | 15 (11.2) | 16 (13.8) | 0.603 | 9 (11.8) | 9 (11.8) | 1 | / | / | / | / | / | / |
| Etc. | 21 (15.7) | 17 (14.7) | 0.856 | 11 (14.5) | 11 (14.5) | 1 | / | / | / | / | / | / |
Figure 1Differences in expression levels of KIF2C. Comparison of KIF2C expression levels in (A) TARGET, (B) TARGET_paired, (C) GSE60926, and (D) GSE28460 (**** indicates significance at p value < 0.0001, *** indicates significance at p value < 0.001).
Figure 2Differences in Expression Levels of KIF18B in B cell acute lymphoblastic leukemia (ALL). Comparison of KIF18B expression levels in (A) TARGET, (B) TARGET_paired sample, (C) GSE60926 and (D) GSE28460 (**** indicates significance at p value < 0.0001, *** indicates significance at p value < 0.001, ns means that there is no significant difference).
Figure 3Expression of kif2c in zebrafish embryos is reduced by morpholino injection. (A) RT-PCR analysis of kif2c and β-actin using zebrafish embryos at 4 days post fertilization (dpf). Total RNA was isolated from uninjected embryos and kif2c-targeting morpholino-injected embryos (2.5 ng, 5 ng and 10 ng). Relative expression of kif2c is quantified using ImageJ. (B) Quantitative RT-PCR analysis of kif2c. Relative mRNA expression of kif2c is compared between uninjected control embryos and kif2c-targeting morpholino injected embryos. (*** indicates significance at p value < 0.001).
Figure 4kif2c is linked to the development of lymphocytes in zebrafish embryos. (A) Whole-mount in situ hybridization of uninjected embryos and kif2c-targeting morpholino-injected embryos at 4 days post fertilization (dpf) using the lymphocyte marker rag1. Black arrows indicate the signal of rag1 at thymus. (B) qRT-PCR analysis of rag1 and rag2 expression in uninjected embryos and kif2c-targeting morpholino-injected embryos at 4 dpf. The expression of mRNA is normalized to that of β-actin mRNA levels (*** indicates significance at p value < 0.001, * indicates significance at p value < 0.05).
Figure 5kif2c is related to the maintenance of hematopoietic stem cells. (A) Whole-mount in situ hybridization of uninjected embryos and kif2c-targeting morpholino-injected embryos at 28 hpf using runx1 probe. Black arrows indicate the signal of runx1 at dorsal aorta. (B) Whole-mount in situ hybridization uninjected embryos and kif2c-targeting morpholino-injected embryos at 3 days post fertilization (dpf) using cmyb probe. Black arrows indicate the signal of cmyb at caudal hematopoietic tissue.
Figure 6kif2c is important for survival of hematopoietic stem cells through regulation of DNA damage. (A) Lateral view of caudal hematopoietic tissue (CHT) using confocal microscope. Confocal imaging of 5-ethynyl-2’deoxyuridine (EdU)-stained control and kif2c-targeting morpholino-injected embryos. Right panel shows quantified data (n.s. indicates significance at p value > 0.05). Red frames indicate caudal hematopoietic tissue. (B) Apoptosis was observed by Acridine orange (AO) staining of control and kif2c-targeting morpholino-injected embryos. Right panel shows quantified data (*** indicates significance at p value < 0.001). Red frames indicate caudal hematopoietic tissue. (C) Whole-mount in situ hybridization uninjected embryos and kif2c-targeting morpholino-injected embryos at 3 days post fertilization (dpf) using p53 probe. Red frames indicate caudal hematopoietic tissue.